Germ Cell, Stromal, and other Ovarian Tumors

Clinical Gynecologic Oncology

Volumn , Issue , 2007, Pages 369-395

  Bidus, Michael A ^a   Zahn, Christopher M ^b   Rose, G Scott ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882542771     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032303978-9.50015-0     Document Type: Chapter

References (196)

1. Abell MR, Johnson VJ, Holtz F Ovarian neoplasms in childhood and adolescence. I: Tumors of germ cell origin. Am J Obstet Gynecol 1965, 92:1059.
2. Albites V Solid teratoma of the ovary with malignant gliomatosis peritonei. Int J Gynaecol Obstet 1974, 12:59.
3. Asadourian LA, Taylor HB Dysgerminoma: An analysis of 105 cases. Obstet Gynecol 1969, 33:370.
4. Ashley DJB Origin of teratomas. Cancer 1983, 32:390.
5. Baker BA, Frickey L, Yu IT, et al. DNA content of ovarian immature teratomas and malignant germ cell tumors. Gynecol Oncol 1998, 71:14.
6. Beiner ME, Gotlieb WH, Korach Y, et al. Cystectomy for immature teratoma of the ovary. Gynecol Oncol 2004, 93:381.
7. Bianchi UA, Sartori E, Favallin G. New trends in treatment of ovarian dysgerminoma. Gynecol Oncol 1986, 23:246.
8. Boczkowski K, Teter J, Sternadel Z. Sibship occurrence of XY gonadal dysgenesis with dysgerminoma. Am J Obstet Gynecol 1972, 113:952.
9. Bonazzi C, Peccatori F, Colombo N, et al. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients. Obstet Gynecol 1994, 84:598.
10. Bower M, Eife K, Holden L, et al. Chemotherapy for ovarian germ cell tumours. Eur J Cancer 1996, 32a:593.
11. Breen JL, Neubecker RD Malignant teratoma of the ovary: An analysis of 17 cases. Obstet Gynecol 1963, 21:669.
12. Casey AC, Bhodauria S, Shapter A, et al. Dysgerminoma: The role of conservative surgery. Gynecol Oncol 1996, 63:352.
13. Cooper MA, Einhorn LH Maintenance chemotherapy with daily oral etoposide following salvage therapy in patients with germ cell tumors. J Clin Oncol 1995, 13:1167.
14. Creasman WT, Soper JT Assessment of contemporary management of germ cell malignancies of the ovary. Am J Obstet Gynecol 1985, 153:828.
15. Creasman WT, et al. Germ cell malignancies of the ovary. Obstet Gynecol 1979, 53:226.
16. Culin S, Lhomme C, Kattan J, et al. Pure malignant immature teratoma of the ovary: The role of chemotherapy and second-look surgery. Int J Gynecol Oncol 1995, 5:432.
17. Curry SL, Smith JP, Gallagher HS Malignant teratoma of the ovary: Prognostic factors and treatment. Am J Obstet Gynecol 1978, 131:845.
18. Curtin JP, Morrow CP, Ablaing GD, Schlaerth JB Malignant germ cell tumors of the ovary: 20-year report of LAC-USC Women's Hospital. Int J Gynecol Cancer 1994, 4:29.
19. Curtin JP, Rubin SL, Hoskins WJ, et al. Second look laparotomy in endodermal sinus tumor: A report of two patients with normal levels of alpha-fetoprotein and residual tumor at re-exploration. Obstet Gynecol 1989, 73:93.
20. Cushing B, Giller R, Ablin A, et al. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group. Am J Obstet Gynecol 1999, 181:353.
21. Cushing B, Giller R, Cullen JW, et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A Pediatric Intergroup Study-Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol 2004, 22:2691.
22. Dark GG, Bower M, Newlands ES, et al. Surveillance policy for stage I ovarian germ cell tumours. J Clin Oncol 1997, 15:620.
23. De Palo G, et al. Natural history of dysgerminoma. Am J Obstet Gynecol 1982, 143:799.
24. De Santis M, Bercherer A, Bokemyer C, et al. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 2004, 22(6):1034.
25. Dimopoulos MA, Papadopoulou M, Andrepoulou E, et al. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: A Hellenic Cooperative Oncology Group Study. Gynecol Oncol 1998, 70:70.
26. Dimopoulos MA, Papadimitriou C, Hamilos G, et al. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study. Gynecol Oncol 2004, 95:695.
27. DiSaia PJ, et al. Chemotherapeutic retroconversion of immature teratoma of the ovary. Obstet Gynecol 1977, 49:346.
28. Edraki B, Schwartz PE Fertility after conservative treatment of ovarian immature teratoma. Int J Gynecol Cancer 1997, 7:227.
29. Emig OR, Hertig AT, Rowe FJ Gynandroblastoma of the ovary: Review and report of a case. Obstet Gynecol 1959, 13:135.
30. Favara BE, Franciosi RA Ovarian teratoma and neuroglial implants on the peritoneum. Cancer 1973, 31:678.
31. Forney JP, DiSaia PJ, Morrow CP Endodermal sinus tumor: A report of two sustained remissions treated postoperatively with a combination of actinomycin D, 5-fluorouracil and cyclophosphamide. Obstet Gynecol 1975, 45:186.
32. Freel JH, et al. Dysgerminoma of the ovary. Cancer 1979, 43:798.
33. Fujita M, Inque M, Tanizawa, et al. Retrospective review of 41 patients with endodermal sinus tumor of the ovary. Int J Gynecol Cancer 1993, 3:329.
34. Gallion HH, Van Nagell JR, Donaldson ES, et al. Ovarian dysgerminoma: Report of seven cases and review of the literature. Am J Obstet Gynecol 1988, 158:591.
35. Gallion H, Van Nagell JR, Pall BF Therapy of endodermal sinus tumors of the ovary. Am J Obstet Gynecol 1979, 135:447.
36. Gerbie MV, Brewer JI, Taminni H. Primary choriocarcinoma of the ovary. Obstet Gynecol 1975, 46:720.
37. Gershenson DM Management of early ovarian cancer: Germ cell and sex-cord stromal tumors. Gynecol Oncol 1994, 55:S62.
38. Gershenson DM Menstrual and reproductive function after treatment with combined chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 1988, 6:270.
39. Gershenson DM Update on malignant ovarian germ cell tumors. Cancer 1993, 71:1581.
40. Gershenson DM, Del Junco G, Copeland LJ Mixed germ cell tumors of the ovary. Obstet Gynecol 1985, 64:200.
41. Gershenson DM, Morris M, Cangir A, et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 1990, 8:715.
42. Gershenson DM, et al. Endodermal sinus tumor of the ovary. Obstet Gynecol 1983, 61:194.
43. Gordon A, Lipton D, Woodruff JD Dysgerminoma: A review of 158 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynecol 1981, 58:497.
44. Hart WR, Burkons DM Germ cell neoplasms arising in gonadoblastomas. Cancer 1979, 43:669.
45. Jacobs A, et al. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine and bleomycin. Obstet Gynecol 1982, 59:129.
46. Jimerson GK, Woodruff JD Ovarian extra-embryonal teratoma. I. Endodermal sinus tumor. Am J Obstet Gynecol 1977, 127:73.
47. Kammerer-Doak D, Baurick K, Black W, et al. Case report: Endodermal sinus tumor and embryonal carcinoma of the ovary in a 53-year-old woman. Gynecol Oncol 1996, 63:133.
48. Kojs Z, Urbanski K, Mitus J, et al. Pure immature teratoma of the ovary: Analysis of 22 cases. Eur J Gynecol Oncol 1997, 28:534.
49. Koller O, Gjonnaess H. Dysgerminoma of the ovary: A clinical report of 20 cases. Acta Obstet Gynecol Scand 1964, 43:268.
50. Kollmannsberger C, Hartmann JT, Kanz L, et al. Therapy-related malignancies following treatment of germ cell cancer. Int J Cancer 1999, 83:860.
51. Kosloske AM, et al. Management of immature teratoma of the ovary in children by conservative resection and chemotherapy. J Pediatr Surg 1976, 11:839.
52. Krepart G, et al. The treatment of dysgerminoma of the ovary. Cancer 1978, 41:986.
53. Kurman RJ, Norris HJ Embryonal carcinoma of the ovary-a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. Cancer 1976, 38:2420.
54. Kurman RJ, Norris HJ Endodermal sinus tumor of the ovary: A clinical and pathological analysis of 71 cases. Cancer 1976, 38:2404.
55. Kurman RJ, Norris HJ Malignant germ cell tumors of the ovary. Hum Pathol 1977, 8:551.
56. Kurman RJ, Norris HJ Malignant mixed germ cell tumors of the ovary: A clinical and pathological analysis of 30 cases. Obstet Gynecol 1976, 48:579.
57. Kurman RJ, Scardino PT, Waldman TA, et al. Malignant germ cell tumors of the ovary and testis: An immunologic study of 69 cases. Ann Clin Lab Sci 1979, 9:462.
58. La Polla JP, Bende J, Vigliotti AP, et al. Dysgerminoma of the ovary. Obstet Gynecol 1987, 69:859.
59. Low JJ, Perrin LC, Crandon AJ, et al. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 2000, 89:391.
60. Lucraft HH A review of 33 cases of ovarian dysgerminoma emphasizing the role of radiotherapy. Clin Radiol 1979, 30:585.
61. Messing MJ, Gershenson DM, Morris M, et al. Primary treatment failure in patients with malignant ovarian germ cell neoplasms. Int J Gynecol Cancer 1992, 2:295.
62. Morris HHB, La Vecchia C, Draper GJ Endodermal sinus tumor and embryonal carcinoma of the ovary in children. Gynecol Oncol 1985, 21:7.
63. Munkarah A, Gershenson DM, Leverback C, et al. Salvage surgery for chemotherapy ovarian germ cell tumors. Gynecol Oncol 1994, 55:217.
64. Neubecker RD, Breen JL Gynandroblastoma: A report of five cases, with a discussion of the histogenesis and classification of ovarian tumors. Am J Clin Pathol 1982, 38:60.
65. Newlands ES, et al. Potential for cure in metastatic ovarian teratomas and dysgerminomas. Br J Obstet Gynaecol 1982, 89:555.
66. Norris HJ, Zirkin HJ, Benson WL Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer 1976, 37:2359.
67. Parvez D, et al. Long-term disease-free survival in immature teratoma of the ovary. Cancer 1982, 50:159.
68. Patel PS, Sharma VM, Raval GN, et al. Serum lactate dehydrogenase levels in malignant germ cell tumors of the ovary. Int J Gynecol Cancer 1996, 6:328.
69. Peccatori F, Bonazzi C, Chiari S, et al. Surgical management of malignant ovarian germ cell tumors: 10 years' experience of 129 patients. Obstet Gynecol 1995, 86:367.
70. Robboy SJ, Scully RE Ovarian teratoma with glial implants on the peritoneum: an analysis of 12 cases. Hum Pathol 1970, 1:643.
71. Rosenshein NB, et al. Pregnancy following chemotherapy for an ovarian immature embryonal teratoma. Gynecol Oncol 1979, 8:234.
72. Roth LM, Panganiban WG Gonadal and extragonadal yolk sac carcinomas: A clinicopathologic study of 14 cases. Cancer 1976, 37:812.
73. Russell P, Pointer DM The pathologic assessment of ovarian neoplasms. V: The germ cell tumors. Pathology 1982, 14:47.
74. Santesson L, Marrubini G. Clinical and pathological survey of ovarian embryonal carcinomas, including so-called "mesonephromas" (Schiller) or "mesoblastomas" (Teilum), treated at the Radiumhemmet. Acta Obstet Gynecol Scand 1957, 36:399.
75. Schellhas HF, et al. Germ cell tumors associated with XY gonadal dysgenesis. Am J Obstet Gynecol 1971, 109:1197.
76. Schwartz PE, Chambers SK, Chambers JT, et al. Ovarian germ cell malignancies: The Yale University experience. Gynecol Oncol 1992, 45:26.
77. Scully RE Gonadoblastoma: A review of 74 cases. Cancer 1970, 25:1340.
78. Scully RE Ovarian tumors: A review. Am J Pathol 1977, 87:686.
79. Scully RE Special ovarian tumors and their management. Int J Radiat Oncol Biol Phys 1982, 8:1419.
80. Segelov E, Campbell J, Ng M, et al. Cisplatin-based chemotherapy for ovarian germ cell malignancies: The Australian experience. J Clin Oncol 1994, 12:378.
81. Sessa C, et al. Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumors of the ovary. Obstet Gynecol 1987, 70:220.
82. Shefren G, Collin J, Soriero O. Gliomatosis peritonei with malignant transformation: A case report and review of the literature. Am J Obstet Gynecol 1991, 164:1617.
83. Slate RE, et al. Vincristine, dactinomycin and cyclophosphamide in treatment of germ cell tumors of the ovary. Cancer 1985, 56:243.
84. Slayton RE, Park RC, Schenberg SG, et al. Vincristine, dactinomycin and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. Cancer 1985, 56:243.
85. Slayton RE, et al. Treatment of malignant ovarian germ cell tumors; response to vincristine, dactinomycin, and cyclophosphamide (preliminary report). Cancer 1978, 42:390.
86. Smith EB, Clarke-Pearson DL, Creasman WT A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies. Am J Obstet Gynecol 1984, 150:927.
87. Tangir J, Zelterman D, Ma W, et al. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 2003, 101:251.
88. Teilum G Classification of endodermal sinus tumor (mesoblastoma vitellinum) and so-called "embryonal carcinoma" of the ovary. Acta Pathol Microbiol Scand 1965, 64:407.
89. Tewfik HH, Tewfik FA, Latourette HB A clinical review of seventeen patients with ovarian dysgerminoma. Int J Radiat Oncol Biol Phys 1982, 8:1705.
90. Thomas EM, Dembo AJ, Hacker NF, et al. Current therapy for dysgerminoma of the ovary. Obstet Gynecol 1987, 70:268.
91. Thomas GM, et al. Current therapy for dysgerminoma of the ovary. Obstet Gynecol 1987, 70:268.
92. Truong LD, Jurco S, McGavran MH Gliomatosis peritonei. Am J Surg Pathol 1982, 6:443.
93. Ungerleider RS, et al. Endodermal sinus tumor: The Stanford experience and the first reported case arising in the vulva. Cancer 1978, 41:1627.
94. Williams SD, Blessing JA, Liao S-Y, et al. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: A trial of the Gynecologic Oncology Group. J Clin Oncol 1994, 12:701.
95. Williams SD Current management of ovarian germ cell tumors. Oncology 1994, 8:53.
96. Williams SD, Birch R, Einhorn LH, et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 1987, 316:1435.
97. Williams SD, Blessing JA, DiSaia PJ, et al. Second look laparotomy in ovarian germ cell tumors: The Gynecologic Oncology Group Experience. Gynecol Oncol 1994, 52:287.
98. Williams SD, Blessing JA, Moore DM, et al. Cisplatin, vinblastine and bleomycin in advanced and recurrent ovarian germ cell tumors. Ann Intern Med 1989, 111:22.
99. Zanetta G, Bonnazi C, Cantu M, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 2001, 19:1015.
100. Ala-Fossi SL, Maenpaa J, Aine R, et al. Prognostic significance of p53 expression in ovarian granulosa cell tumors. Gynecol Oncol 1997, 66:475.
101. Anderson WR, Levine AJ, MacMillan D. Granulosa-theca cell tumors: Clinical and pathologic study. Am J Obstet Gynecol 1971, 110:32.
102. Bremmer WJ Inhibin: from hypothesis to clinical application. N Engl J Med 1989, 321:790.
103. Brewer CA, Shevlin D. Encouraging response of an advanced steroid-cell tumor to GNRH agonist therapy. Obstet Gynecol 1998, 92:661.
104. Brown J, Shvartsman HS, Deavers MT, Burke TW, Munsell MF, Gershenson DM The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol 2004, 22(17):3517.
105. Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 2005, 97(2):489.
106. Burger HG Clinical utility of inhibin measurements. J Clin Endocrin Metab 1993, 76:1391.
107. Camlibel FT, Caputo TA Chemotherapy of granulosa cell tumors. Am J Obstet Gynecol 1983, 145:763.
108. Chalvardjian A, Scully RE Sclerosing stromal tumors of the ovary. Cancer 1973, 31:664.
109. Chan JK, Zhang M, Kaleb V, Loizzi V, Benjamin J, Vasilev S, Osann K, DiSaia PJ Prognostic factors responsible for survival in sex cord stromal tumors of the ovary-a multivariate analysis. Gynecol Oncol 2005, 96:204-209.
110. Colombo N, Essa C, Landonin F, et al. Cisplatin, vinblastine and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol 1986, 67:265.
111. Colombo N, Parma G, Franchi D. An active chemotherapy regimen for advanced ovarian sex cord-stromal tumors. Gynecol Oncol 1999, 72:129.
112. Cool I, O'Brien M, Charnock M, et al. Inhibin as a marker for ovarian cancer. Br J Cancer 1995, 71:1046.
113. Cronje HS, Niemand I, Bam RH, Woodruff JD Review of the granulosa-theca cell tumors from the Emil Novak Ovarian Tumor Registry. Am J Obstet Gynecol 1999, 180:323.
114. Dinnerstein AJ, O'Leary JA Granulosa-theca cell tumors: A clinical review of 102 patients. Obstet Gynecol 1968, 31:654.
115. DiSaia PJ, et al. A temporary response of recurrent granulosa cell tumor to Adriamycin. Obstet Gynecol 1978, 52:355.
116. Evans AJ, et al. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 1980, 55:213.
117. Finan MA, Roberts WS, Kavanagh JJ Ovarian Sertoli-Leydig cell tumor: success with salvage therapy. Int J Gynecol Cancer 1993, 3:189.
118. Gard GB, Mulvany N, Quinn MA Alpha-fetoprotein and Sertoli-Leydig cell tumor. Int J Gynecol Cancer 1998, 8:499.
119. Gershenson DM Management of early ovarian cancer: Germ cell and sex cord-stromal tumors. Gynecol Oncol 1994, 55:S62.
120. Gershenson DM, Copeland LJ, Kavanagh JJ, et al. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 1987, 70:765.
121. Gershenson DM, Morris M, Burke TW, et al. Treatment of poor prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol 1996, 87(4):527.
122. Gillibrand PN Granulosa-theca cell tumors of the ovary associated with pregnancy: Case report and review of the literature. Am J Obstet Gynecol 1966, 94:1108.
123. Gusberg SB, Kardon P. Proliferative endometrial response to theca-granulosa cell tumors. Am J Obstet Gynecol 1971, 111:633.
124. Healy DL, Burger HG, Mamers P, et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med 1993, 329:1539.
125. Hines JF, Khalafia MA, Moore JL, et al. Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: A case report and review of the literature. Gynecol Oncol 1996, 60:484.
126. Homesley HD, Bundy BN, Hurteau JA, Roth LM Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group Study. Gynecol Oncol 1999, 72:131.
127. Ishiko O, Yoshida H, Sumi T. Vascular endothelial growth factor levels in pleural and peritoneal fluid in Meig's syndrome. Eur J Obstet Gynecol Reprod Biol 2001, 98:129.
128. Jacobs AJ, Deppe G, Cohen CJ Combination chemotherapy of ovarian granulosa cell tumor with cisplatinum and doxorubicin. Gynecol Oncol 1982, 14:294.
129. Jobling T, Mamers P, Healy DL, et al. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol 1994, 55:285.
130. Kietlinska Z, Pietrzak K, Drabik M. The management of granulosa-cell tumors of the ovary based on long-term follow up. Eur J Gynecol Oncol 1993, 14:118.
131. Lack EE, et al. Granulosa-theca cell tumors in premenarchal girls: a clinical and pathologic study of ten cases. Cancer 1981, 48:1846.
132. Malstrom H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: Prognostic factors and outcome. Gynecol Oncol 1994, 52:50.
133. Martikainen H, Penttinen J, Huhtaniemi I, Kauppila A. Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy. Gynecol Oncol 1989, 35:406.
134. Maxwell GL, Soisson AP, Miles P Failure of gonadotropin releasing hormone therapy in patients with metastatic ovarian sex cord stromal tumors. Oncology 1994, 51(4):356.
135. Norris HJ, Taylor HB Prognosis of granulosa-theca tumors of the ovary. Cancer 1968, 21:255.
136. Norris HJ, Taylor HB Virilization associated with cystic granulosa tumors. Obstet Gynecol 1969, 34:629.
137. Novak ER, Long JH Arrhenoblastoma of the ovary: A review of the Ovarian Tumor Registry. Am J Obstet Gynecol 1965, 92:1082.
138. Novak ER, Mattingly RF Hilus cell tumor of the ovary. Obstet Gynecol 1960, 15:425.
139. Novak ER, et al. Feminizing gonadal stromal tumors: Analysis of granulosa-theca cell tumors of the Ovarian Tumor Registry. Obstet Gynecol 1971, 38:701.
140. Pautier P, Lhomme C, Culine S, et al. Adult granulosa cell tumor of the ovary: A retrospective study of 45 cases. Int J Gynecol Cancer 1997, 7:58.
141. Powell JL, Otis CN Management of advanced juvenile granulosa cell tumor of the ovary: Case report. Gynecol Oncol 1997, 64:282.
142. Rey RA, Lhomme C, Marcillac I. Antimullerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol 1996, 174:958.
143. Roush GR, El-Nagger AK, Abdul-Karim FW Granulosa cell tumor of the ovary: A clinicopathologic and flow cytometric DNA analysis. Gynecol Oncol 1995, 56:430.
144. Segal R, DePetrillo AD, Thomas G. Clinical review of adult granulosa cell tumors of the ovary. Gynecol Oncol 1995, 56:338.
145. Stenwig JT, Hazekamp J, Beecham J. Granulosa cell tumors of the ovary: A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 1979, 7:136.
146. Tresukosol D, Kudelka AP, Edwards CL, et al. Recurrent ovarian granulosa cell tumor: A case report of a dramatic response to Taxol. Int J Gynecol Cancer 1995, 5:156.
147. Young RH, Scully RE Ovarian Sertoli-Leydig cell tumors with a retiform pattern: A problem in histopathologic diagnosis: A report of 25 cases. Am J Surg Pathol 1983, 7:755.
148. Young RH, Welch WR, Dickersin GR, Scully RE Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum. Cancer 1982, 50:1384.
149. Wolf JK, Mullen J, Eifel PJ, et al. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol 1999, 73:35.
150. Zaloudek C, Norris HJ Granulosa tumors of the ovary in children: A clinical and pathological study of 32 cases. Am J Surg Pathol 1982, 6:503.
151. Zaloudek C, Norris HJ Sertoli-Leydig tumors of the ovary: A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 1984, 8:405.
152. Azoury RS, Woodruff JD Primary ovarian sarcomas: Report of 43 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynecol 1971, 37:920.
153. Bicher A, Levenback C, Silva EG, et al. Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy. Obstet Gynecol 1995, 85:735.
154. Blackwell WJ, et al. Dermoid cysts of the ovary, their clinical and pathologic significance. Am J Obstet Gynecol 1946, 51:151.
155. Dehner LP, Norris HJ, Taylor HB Carcinosarcomas and mixed mesodermal tumors of the ovary. Cancer 1971, 27:207.
156. DiSaia PJ, Pecorelli S. Gynecological sarcomas. Semin Surg Oncol 1994, 10:369.
157. Dunn S Bilateral virilizing hilus (Leydig) cell tumors of the ovary. Acta Obstet Gynecol Scand 1994, 73:76.
158. Einhorn LH, Donohue J. Cis-diamminedichloro-platinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977, 87:293.
159. Ferenczy A, Okagaki T, Richart RM Para-endocrine hypercalcemia in ovarian neoplasms: Report of mesonephroma with hypercalcemia and review of literature. Cancer 1971, 27:427.
160. Fox H, Langley FA, Govan ADT, et al. Malignant lymphoma presenting as ovarian tumor: A clinicopathologic analysis of 34 cases. Br J Obstet Gynaecol 1998, 95:386.
161. Fox LP, Stamm WJ Krukenberg tumor complicating pregnancy: Report of a case with androgenic activity. Am J Obstet Gynecol 1965, 92:702.
162. Genadry R, Parmley T, Woodruff JD Case report-secondary malignancies in benign cystic teratomas. Gynecol Oncol 1979, 8:246.
163. Hale RW Krukenberg tumor of the ovaries: A review of 81 records. Obstet Gynecol 1968, 22:221.
164. Joshi VV Primary Krukenberg tumor of ovary: A review of literature and case report. Cancer 1968, 22:1199.
165. Judd HL, et al. Maternal virilization developing during a twin pregnancy: Demonstration of excess ovarian androgen production associated with theca-lutein cysts. N Engl J Med 1973, 288:118.
166. Krumerman MS, Chung A. Squamous carcinoma arising in benign cystic teratoma of the ovary. Cancer 1977, 29:1237.
167. Monk BJ, Nieberg R, Berek JS Primary leiomyosarcoma of the ovary in a premenarchal female. Gynecol Oncol 1993, 48:389.
168. Monterroso V, Jaffe ES, Merino MJ, Medeiros LJ Malignant lymphomas involving the ovary: A clinicopathologic analysis of 39 cases. Am J Surg Pathol 1993, 17:154.
169. Peterson WF, et al. Benign cystic teratomas of the ovary: A clinico-statistical study of 1007 cases with a review of the literature. Am J Obstet Gynecol 1955, 70:568.
170. Pfeiffer P, Hardt-Madsen M, Rex S, et al. Malignant mixed müllerian tumors of the ovary report of 13 cases. Acta Obstet Gynecol Scand 1991, 70:79.
171. Prendiville J, Murphy D, Renninson J, et al. Carcinosarcoma of the ovary treated over a 10-year period at the Christie Hospital. Int J Gynecol Cancer 1994, 4:200.
172. Qizilbach AH, et al. Functioning primary carcinoid tumor of the ovary. Am J Clin Pathol 1974, 62:629.
173. Robboy SJ, Scully RE, Norris HJ Carcinoid metastatic to the ovary: A clinicopathologic analysis of 35 cases. Cancer 1974, 33:798.
174. Robboy SJ, Scully RE, Norris HJ Primary trabecular carcinoid of the ovary. Obstet Gynecol 1977, 49:202.
175. Sood AK, Sorosky JI, Gelder MS, Buller RE Primary ovarian sarcoma, analysis of prognostic variables and the role of surgical cytoreduction. Cancer 1998, 82:1731.
176. Spadoni LR, et al. Virilization coexisting with Krukenberg tumor during pregnancy. Am J Obstet Gynecol 1965, 92:981.
177. Woodruff D, Noli Castillo RD, Novak ER Lymphoma of the ovary: A study of 35 cases from the Ovarian Tumor Registry of the American Gynecological Society. Am J Obstet Gynecol 1963, 85:912.
178. Woodruff JD, Novak ER The Krukenberg tumor: A study of 48 cases from the Ovarian Tumor Registry. Obstet Gynecol 1960, 15:351.
179. Abell MR, Holtz F Ovarian neoplasms in childhood and adolescence. II: Tumors of non-germ cell origin. Am J Obstet Gynecol 1965, 93:850.
180. Ablin AR Malignant germ cell tumors in children. Front Radiat Ther Oncol 1982, 16:141.
181. Acosta A, Kaplan AL, Kaufman RH Gynecologic cancer in children. Am J Obstet Gynecol 1972, 112:944.
182. Barber HRK Ovarian cancers in childhood. Int J Radiat Oncol Biol Phys 1982, 8:1427.
183. Barber HRK, Graber EA Gynecological tumors in childhood and adolescence. Obstet Gynecol Surv 1973, 28:357.
184. Breen JL, Bonamo JF, Maxson WS Genital tract tumors in children. Pediatr Clin North Am 1981, 28:355.
185. Breen JL, Neubecker RD Ovarian malignancy in children with special reference to the germ cell tumors. Ann N Y Acad Sci 1962, 142:208.
186. Cangir A, Smith J, van Eys J Improved prognosis in children with ovarian cancers following modified VAC (vincristine, sulfate, dactinomycin, and cyclophosphamide) chemotherapy. Cancer 1978, 42:1234.
187. Carlson DH, Griscom NT Ovarian cysts in the newborn. AJR Am J Roentgenol 1972, 116:664.
188. Groeber WR Ovarian tumors during infancy and childhood. Am J Obstet Gynecol 1963, 86:1027.
189. Hernandez W, et al. Mixed mesodermal sarcoma of the ovary. Obstet Gynecol 1977, 49:59.
190. Holtz F, Hart WR Krukenberg tumors of the ovary: A clinicopathologic analysis of 27 cases. Cancer 1982, 50:2438.
191. Kempers RD, et al. Struma ovarii-ascitic, hyperthyroid and asymptomatic syndromes. Ann Intern Med 1970, 72:883.
192. Marshall JR Ovarian enlargement in the first year of life: Review of 45 cases. Ann Surg 1965, 161:372.
193. Moore JC, Schifrin BS, Erez S. Ovarian tumors in infancy, childhood and adolescence. Am J Obstet Gynecol 1967, 99:913.
194. Norris HJ, Jensen RD Relative frequency of ovarian neoplasms in children and adolescents. Cancer 1972, 39:713.
195. Smith JP, Rutledge F, Sutow WW Malignant gynecologic tumors in children: Current approaches to treatment. Am J Obstet Gynecol 1973, 116:261.
196. Weinblatt ME, Ortega JA Treatment of children with dysgerminoma of the ovary. Cancer 1982, 49:2608.